BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04884191-completion@plaintrial.com
DTSTAMP:20260926T052624Z
DTSTART;VALUE=DATE:20190904
SUMMARY:Phase 2 Study: An Open-Label\, Randomized\, Phase 2 Dose-Finding St
 udy of Pacritinib in Patients With Primary Myelofibrosis\, Post-Polycythem
 ia Vera Myelofibrosis\, or Post- Essential Thrombocythemia Myelofibrosis P
 reviously Treated With Ruxolitinib — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04884191
URL:https://plaintrial.com/trial/NCT04884191
END:VEVENT
END:VCALENDAR